We could unravel a functional switch of the LC by diminishing the classical antigen‐presenting and T cell interacting factors and the directed migratory activity, but promoting the release of IL‐18 and IL‐1β, both of which can drive T2 immunity indirectly and are associated with AD. This evidence concerns the gene IL1B and Alzheimer disease.